| Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes E Riquelme, Y Zhang, L Zhang, M Montiel, M Zoltan, W Dong, P Quesada, ... Cell 178 (4), 795-806. e12, 2019 | 998 | 2019 |
| Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer Y Zhang, V Chandra, E Riquelme Sanchez, P Dutta, PR Quesada, ... Journal of Experimental Medicine 217 (12), 2020 | 260 | 2020 |
| Integrins modulate TCR signaling by constraining actin flow at the immunological synapse KI Jankowska, EK Williamson, NH Roy, D Blumenthal, V Chandra, ... Frontiers in Immunology 9, 25, 2018 | 92 | 2018 |
| Mouse T cell priming is enhanced by maturation-dependent stiffening of the dendritic cell cortex D Blumenthal, V Chandra, L Avery, JK Burkhardt Elife 9, e55995, 2020 | 78 | 2020 |
| Therapeutic potential of microbial modulation in pancreatic cancer V Chandra, F McAllister Gut 70 (8), 1419-1425, 2021 | 22 | 2021 |
| CD73-dependent adenosine signaling through Adora2b drives immunosuppression in ductal pancreatic cancer EY Faraoni, K Singh, V Chandra, O Le Roux, Y Dai, I Sahin, BJ O'Brien, ... Cancer Research 83 (7), 1111-1127, 2023 | 11 | 2023 |
| Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation V Chandra, L Li, O Le Roux, Y Zhang, RM Howell, DN Rupani, ... Cancer cell 42 (1), 85-100. e6, 2024 | 5 | 2024 |
| Pancreatic cancer ductal cell of origin drives CD73-dependent generation of immunosuppressive adenosine K Singh, EY Faraoni, Y Dai, V Chandra, E Vucic, T Mills, M Pruski, T Clark, ... bioRxiv, 2021.11. 29.470415, 2021 | 4 | 2021 |
| Adar1 deletion causes degeneration of the exocrine pancreas via Mavs-dependent interferon signaling DN Rupani, FI Thege, V Chandra, H Rajaei, RW Cowan, SM Wörmann, ... Development 150 (2), dev201097, 2023 | 1 | 2023 |
| Cytometry of Mass for Murine Immunoprofiling V Chandra, F McAllister, JK Burks Cancer Immunoprevention: Methods and Protocols, 129-137, 2022 | 1 | 2022 |
| Mouse Models to Study Secondary Cancer Prevention L Li, V Chandra, F McAllister, Y Zhang Cancer Immunoprevention: Methods and Protocols, 215-223, 2022 | 1 | 2022 |
| T cell priming is enhanced by maturation-dependent stiffening of the dendritic cell cortex D Blumenthal, L Avery, V Chandra, JK Burkhardt bioRxiv, 680132, 2020 | 1 | 2020 |
| Assessing Engraftment Following Fecal Microbiota Transplant C Herman, BM Barker, TF Bartelli, V Chandra, R Krajmalnik-Brown, ... arXiv preprint arXiv:2404.07325, 2024 | | 2024 |
| Intermittent fasting-remodeled gut microbiota improves anti-tumor immunity in pancreatic cancer L Li, V Chandra, O Le Roux, RM Howell, V Tahan, N Putluri, J Petrosino, ... Cancer Research 84 (6_Supplement), 6692-6692, 2024 | | 2024 |
| Differences in gut microbial composition alter pancreatic tumorigenesis RM Howell, JE Ortiz, OL Roux, V Chandra, L Li, PK Bhattacharya, ... Cancer Research 84 (6_Supplement), 2176-2176, 2024 | | 2024 |
| Tumor microbial burden is regulated by mast cells and determines immunotherapy responses H Rajaei, JH Jang, H Liu, EY Faraoni, O Le Roux, V Chandra, V Tahan, ... Cancer Research 84 (6_Supplement), 6673-6673, 2024 | | 2024 |
| Tumor-resident microbes: the new kids on the microenvironment block L Li, V Chandra, F McAllister Trends in Cancer, 2024 | | 2024 |
| Interrogating host-intratumoral microbial interactions in pancreatic cancer V Chandra, H Rajaei, S Baydogan, J Gomez, S Ferri-Borgogno, A Maitra, ... Cancer Research 83 (7_Supplement), 5918-5918, 2023 | | 2023 |
| Elucidating mechanisms involved in host microbial-tumor interactions V Chandra | | 2023 |
| Abstract IA013: Preclinical testing of CD73 inhibitors for pancreatic cancer immunoprevention L Ballew, K Singh, V Chandra, T Mills, EY Faraoni, V Mota, T Clark, ... Cancer Prevention Research 15 (12_Supplement_2), IA013-IA013, 2022 | | 2022 |
FLORENCIA MCALLISTERUniversity of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
